WOOJUNG BIO Statistics

Total Valuation

WOOJUNG BIO has a market cap or net worth of KRW 26.17 billion. The enterprise value is 73.14 billion.

Market Cap	26.17B
Enterprise Value	73.14B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

WOOJUNG BIO has 15.88 million shares outstanding. The number of shares has increased by 39.65% in one year.

Current Share Class	n/a
Shares Outstanding	15.88M
Shares Change (YoY)	+39.65%
Shares Change (QoQ)	-14.22%
Owned by Insiders (%)	35.34%
Owned by Institutions (%)	3.87%
Float	9.32M

Valuation Ratios

The trailing PE ratio is 136.85.

PE Ratio	136.85
Forward PE	n/a
PS Ratio	0.46
PB Ratio	0.97
P/TBV Ratio	1.01
P/FCF Ratio	5.92
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.37, with an EV/FCF ratio of 16.54.

EV / Earnings	25.29
EV / Sales	1.49
EV / EBITDA	11.37
EV / EBIT	37.49
EV / FCF	16.54

Financial Position

The company has a current ratio of 0.36, with a Debt / Equity ratio of 1.85.

Current Ratio	0.36
Quick Ratio	0.16
Debt / Equity	1.85
Debt / EBITDA	7.71
Debt / FCF	11.21
Interest Coverage	0.59

Financial Efficiency

Return on equity (ROE) is 10.23% and return on invested capital (ROIC) is 1.55%.

Return on Equity (ROE)	10.23%
Return on Assets (ROA)	1.32%
Return on Capital (ROIC)	1.55%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.53
Inventory Turnover	6.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.86%
50-Day Moving Average	1,897.14
200-Day Moving Average	1,802.88
Relative Strength Index (RSI)	42.06
Average Volume (20 Days)	127,030

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WOOJUNG BIO had revenue of KRW 49.14 billion and earned 2.89 billion in profits. Earnings per share was 12.04.

Revenue	49.14B
Gross Profit	11.81B
Operating Income	1.95B
Pretax Income	2.89B
Net Income	2.89B
EBITDA	6.43B
EBIT	1.95B
Earnings Per Share (EPS)	12.04

Full Income Statement

Balance Sheet

The company has 2.60 billion in cash and 49.56 billion in debt, giving a net cash position of -46.97 billion or -2,957.63 per share.

Cash & Cash Equivalents	2.60B
Total Debt	49.56B
Net Cash	-46.97B
Net Cash Per Share	-2,957.63
Equity (Book Value)	26.81B
Book Value Per Share	1,705.17
Working Capital	-21.69B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.96 billion and capital expenditures -536.83 million, giving a free cash flow of 4.42 billion.

Operating Cash Flow	4.96B
Capital Expenditures	-536.83M
Free Cash Flow	4.42B
FCF Per Share	278.49

Full Cash Flow Statement

Margins

Gross margin is 24.03%, with operating and profit margins of 3.97% and 5.89%.

Gross Margin	24.03%
Operating Margin	3.97%
Pretax Margin	5.89%
Profit Margin	5.89%
EBITDA Margin	13.09%
EBIT Margin	3.97%
FCF Margin	9.00%

Dividends & Yields

WOOJUNG BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.65%
Shareholder Yield	-39.65%
Earnings Yield	0.73%
FCF Yield	16.90%

Stock Splits

The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jul 30, 2019
Split Type	Forward
Split Ratio	2

Scores

WOOJUNG BIO has an Altman Z-Score of 0.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.18
Piotroski F-Score	n/a